progst2 pvdl2
Name
pvdl1
Label
Peripheral vasodilators, exclude dipyridamole (SHHS1)
Description

Participant taking PERIPHERAL VASODILATORS, EXCLUDE DIPYRIDAMOLE within two weeks of the SHHS1 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Tags
PVDL1
Peripheral vasodilators, exclude dipyridamole (SHHS1) vs SHHS Visit Number
Visit 1 Visit 2 CVD Outcomes
Total 5,804 4,080 5,042
No 5,785 - -
Yes 1 - -
Unknown 18 4,080 5,042
Peripheral vasodilators, exclude dipyridamole (SHHS1) vs Age at SHHS1
Visit 1
39.0 to 55.0 years 55.0 to 63.0 years 63.0 to 72.0 years 72.0 to 100.0 years Total
Total 1,451 1,451 1,451 1,451 5,804
No 1,441 1,448 1,451 1,445 5,785
Yes - - - 1 1
Unknown 10 3 - 5 18
Peripheral vasodilators, exclude dipyridamole (SHHS1) vs Gender
Visit 1
Female Male Total
Total 3,039 2,765 5,804
No 3,032 2,753 5,785
Yes - 1 1
Unknown 7 11 18
Peripheral vasodilators, exclude dipyridamole (SHHS1) vs Gender
Visit 2
Female Male Total
Total 2,219 1,861 4,080
No - - -
Yes - - -
Unknown 2,219 1,861 4,080
Peripheral vasodilators, exclude dipyridamole (SHHS1) vs Race
Visit 1
white black native amer/alaskan asian/pacific islander hispanic/mex. amer other Total
Total 4,907 515 11 88 280 3 5,804
No 4,896 510 11 87 278 3 5,785
Yes 1 - - - - - 1
Unknown 10 5 - 1 2 - 18
Peripheral vasodilators, exclude dipyridamole (SHHS1) vs Race
Visit 2
white black native amer/alaskan asian/pacific islander hispanic/mex. amer other Total
Total 3,587 256 8 48 180 1 4,080
No - - - - - - -
Yes - - - - - - -
Unknown 3,587 256 8 48 180 1 4,080